Le Moigne, R, et. al. Treatment of castrated resistant prostate cancer, with EPI-7386, a second generation N-terminal domain androgen receptor inhibitor. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. (Abstract ID B117).

Read More > AACR-NCI-EORTC Poster